Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 9h-carbazol-4-ol
2. 52602-39-8
3. 4-hydroxy Carbazole
4. 4-hydroxycarbazol
5. Chembl46723
6. Mfcd02178385
7. 3d95e7727v
8. 4-hydroxy-9h-carbazole;9h-carbazol-4-ol
9. Ccris 5300
10. Einecs 258-034-9
11. Unii-3d95e7727v
12. 5-hydroxycarbazole
13. 4-hydroxy-carbazole
14. 4-carbazolol
15. 4-hydroxy-9h-carbazole
16. 4-hydroxycarbazole, 95%
17. Ec 258-034-9
18. Schembl151982
19. Ueohatpgkdsulr-uhfffaoysa-
20. Amy8789
21. Dtxsid60200584
22. Bcp08901
23. Zinc2391423
24. Ac2192
25. Bdbm50127697
26. Akos007930133
27. Ac-1995
28. Cs-w017047
29. Ks-1022
30. Skf 106023
31. Skf-106023
32. Bp-12456
33. Sy036873
34. Db-026238
35. Ft-0618683
36. Ft-0681169
37. H1014
38. 02h398
39. A1-00281
40. W-105811
41. Q27257069
42. N-(4-(4-amino-7-(4-hydroxycyclohexyl)-7h-pyrrolo[2,3-d]pyrimidin-5-yl)-2-fluorophenyl)-2,3-dichlorobenzenesulfonamide
| Molecular Weight | 183.21 g/mol |
|---|---|
| Molecular Formula | C12H9NO |
| XLogP3 | 3.5 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 0 |
| Exact Mass | 183.068413911 g/mol |
| Monoisotopic Mass | 183.068413911 g/mol |
| Topological Polar Surface Area | 36 Ų |
| Heavy Atom Count | 14 |
| Formal Charge | 0 |
| Complexity | 218 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A 4-Hydroxycarbazole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 4-Hydroxycarbazole, including repackagers and relabelers. The FDA regulates 4-Hydroxycarbazole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 4-Hydroxycarbazole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 4-Hydroxycarbazole supplier is an individual or a company that provides 4-Hydroxycarbazole active pharmaceutical ingredient (API) or 4-Hydroxycarbazole finished formulations upon request. The 4-Hydroxycarbazole suppliers may include 4-Hydroxycarbazole API manufacturers, exporters, distributors and traders.
4-Hydroxycarbazole Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 4-Hydroxycarbazole GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 4-Hydroxycarbazole GMP manufacturer or 4-Hydroxycarbazole GMP API supplier for your needs.
A 4-Hydroxycarbazole CoA (Certificate of Analysis) is a formal document that attests to 4-Hydroxycarbazole's compliance with 4-Hydroxycarbazole specifications and serves as a tool for batch-level quality control.
4-Hydroxycarbazole CoA mostly includes findings from lab analyses of a specific batch. For each 4-Hydroxycarbazole CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
4-Hydroxycarbazole may be tested according to a variety of international standards, such as European Pharmacopoeia (4-Hydroxycarbazole EP), 4-Hydroxycarbazole JP (Japanese Pharmacopeia) and the US Pharmacopoeia (4-Hydroxycarbazole USP).
LOOKING FOR A SUPPLIER?
